Post-translational
modifications (PTMs) of proteins increase the
functional diversity of the proteome and play crucial regulatory roles
in cellular processes. Ubiquitination is a highly regulated and reversible
PTM accomplished by a complex multistep process with the sequential
action of several specific ubiquitinating (E1–E3) and deubiquitinating
enzymes. The different types of ubiquitination (mono-, poly-mono-,
and poly-) and the presence of several target sites in a single substrate
add to its complexity, which makes the in vitro reconstitution of
this ubiquitin (Ub) machinery a quite cumbersome process. Defects
in components of the ubiquitination process also contribute to disease
pathogenesis, especially cancer and neurodegeneration. This makes
them of interest as potential therapeutic targets. Therefore, the
development of efficient and reliable methods that will generate a
highly homogeneous ubiquitinated peptide and protein conjugate is
a topical subject area of research. In this report, we describe the
development of a simple and efficient in vitro sortase-mediated chemoenzymatic
strategy for semisynthesis of defined and homogeneous ubiquitin conjugates
with more than 90% yield. This was achieved by engineering a sortase
recognition motif in the dynamic C-terminus of ubiquitin and its conjugation
to an isopeptide-linked di-Gly appended peptide LMFK(ε-GG)TEG
corresponding to the ubiquitination site residues 383LMFKTEG389 of p53. The defined and homogeneous ubiquitin conjugates
were also weighed for their recognition propensity by deubiquitinating
enzymes. This facile semisynthesis of ubiquitin conjugates establishes
a simple one-step sortase-mediated chemoenzymatic route for the synthesis
of homogeneous and defined isopeptide-linked polypeptides and will
help in understanding the complexity of the ubiquitination machinery
as well as designing isopeptide drugs and therapeutics.